References
- KwekEBGohSKKohJSPngMAHoweTSAn emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?Injury20083922423118222447
- OdvinaCVZerwekhJERaoDSMaaloufNGottschalkFAPakCYSeverely suppressed bone turnover: a potential complication of alendronate therapyJ Clin Endocrinol Metab2005901294130115598694
- WattsNBDiabDLLong-term use of bisphosphonates in osteoporosisJ Clin Endocrinol Metab2010951555156520173017
- ShaneEBurrDEbelingPRAtypical subtrochanteric and diaphyseal femoral fractures: Report of a Task Force of the American Society for Bone and Mineral ResearchJ Bone Miner Res2010252267229420842676
- NievesJWCosmanFAtypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonatesCurr Osteoporos Rep20108343920425089
- SchilcherJMichaëlssonKAspenbergPBisphosphonate use and atypical fractures of the femoral shaftN Engl J Med20113641728173721542743
- GiustiAHamdyNAPapapoulosSEAtypical fractures of the femur and bisphosphonate therapy; a systematic review of case/case series studiesBone20104716918020493982